Treatment Resistant Depression Trd clinical trials

Explore recruiting treatment resistant depression trd clinical trials.

Recruiting treatment resistant depression trd studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Treatment Resistant Depression Trd trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Quadruple Masked, Dose-Finding Study to Evaluate the Efficacy and Safety of Intranasal BPL-003, with Open Label Extension, in Patients with Treatment Resistant Depression

Poland, Spain, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Dehydroepiandrosterone (DHEA) as augmentation of standard antidepressants in treatment-resistant depression: a randomized controlled trial (DARE-Trial) - A multicenter, randomized, double-blind, placebo-controlled trial with group sequential design

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Advancing PRecise Interventions for resistant DEpression: rebalancing brain networks and investigating the trajectories of antidepressant effect with psilocybin and personalized neuromodulation (PRIDE)

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomized, double-blind, placebo-controlled, Phase 2b trial with an open-label extension to determine the safety and efficacy of GH001 in patients with treatment-resistant depression.

Poland, Czechia, Germany, Spain, Ireland

Therapeutic exploratory (Phase II) EU CTIS Study details

Ketamine maintenance treatment for depression: A multicenter open-label randomized controlled trial

Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

Effect of psilocybin on the positive valence system in treatment-resistant depression: a pilot clinical neuroimaging study

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Treatment Resistant Depression Trd trials by city

Treatment Resistant Depression Trd in Toronto Treatment Resistant Depression Trd in Vancouver Treatment Resistant Depression Trd in Montreal Treatment Resistant Depression Trd in Calgary Treatment Resistant Depression Trd in Edmonton Treatment Resistant Depression Trd in Ottawa Treatment Resistant Depression Trd in Winnipeg Treatment Resistant Depression Trd in Quebec City Treatment Resistant Depression Trd in Hamilton Treatment Resistant Depression Trd in Kitchener Treatment Resistant Depression Trd in London Treatment Resistant Depression Trd in Halifax Treatment Resistant Depression Trd in New York Treatment Resistant Depression Trd in Los Angeles Treatment Resistant Depression Trd in Chicago Treatment Resistant Depression Trd in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease